Molecular Applications Group
This article was originally published in The Gray Sheet
Executive Summary
Palo Alto, California-based bioinformatics technology developer raises $9.5 mil. in equity funding to support expansion of the GeneMine product line, which is used by pharmaceutical companies to research gene sequencing databases, predict protein structure, and discover gene function. The firm's software enables determination of proteome function and the validation of novel drug targets. Since 1997, the firm has placed 10 systems worldwide